April 23, 2020 / 6:27 PM / a month ago

Lawyer largely loses bid to boost fees, avoid paying Avandia MDL attorneys

A Texas lawyer who settled Illinois state court cases over GlaxoSmithKline’s diabetes drug Avandia for $10.5 million has lost an appeal of an order requiring $735,000 of those funds be paid to lawyers in related federal multidistrict litigation.

The Illinois Appellate Court, Fifth District also upheld a judge’s decision to reduce Steven Johnson’s fees by $1.84 million. But it also said a fee sharing agreement he struck with another lawyer was unenforceable, allowing him to claim $242,130 in fees the other attorney was awarded.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/3bsWlEt

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below